福安药业
(300194)
| 流通市值：38.35亿 | | | 总市值：47.11亿 |
| 流通股本：9.68亿 | | | 总股本：11.90亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 839,297,466.77 | 407,493,108.61 | 1,738,291,062.31 | 1,315,372,998.73 |
| 营业总成本 | 760,020,040.99 | 375,586,377.91 | 1,664,041,387.28 | 1,256,272,424.41 |
| 其他经营收益 | | | | |
| 营业利润 | 107,647,634.43 | 59,206,542.3 | 84,179,322.27 | 169,043,115.18 |
| 利润总额 | 105,925,147.76 | 58,911,815.04 | 83,243,576.16 | 167,882,487.49 |
| 净利润 | 95,532,402.66 | 54,775,281.11 | 76,485,660.76 | 165,868,853.75 |
| 每股收益 | | | | |
| 其他综合收益 | -2,204,292.56 | 3,326,978.94 | -29,247,113.56 | -30,787,570.75 |
| 综合收益总额 | 93,328,110.1 | 58,102,260.05 | 47,238,547.2 | 135,081,283 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,840,006,575.39 | 1,814,916,268.3 | 1,946,588,528.13 | 2,057,193,357.17 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,782,261,427.73 | 3,818,278,727.66 | 3,816,855,235.23 | 3,910,221,306.85 |
| 资产总计 | 5,622,268,003.12 | 5,633,194,995.96 | 5,763,443,763.36 | 5,967,414,664.02 |
| 流动负债: | | | | |
| 流动负债合计 | 824,660,717 | 807,674,191.97 | 839,568,255.97 | 943,694,436.16 |
| 非流动负债: | | | | |
| 非流动负债合计 | 395,479,765.31 | 400,106,855.14 | 558,363,519.7 | 569,487,122.92 |
| 负债合计 | 1,220,140,482.31 | 1,207,781,047.11 | 1,397,931,775.67 | 1,513,181,559.08 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,400,628,797.48 | 4,423,813,808.25 | 4,363,770,858.9 | 4,452,374,388.96 |
| 股东权益合计 | 4,402,127,520.81 | 4,425,413,948.85 | 4,365,511,987.69 | 4,454,233,104.94 |
| 负债和股东权益合计 | 5,622,268,003.12 | 5,633,194,995.96 | 5,763,443,763.36 | 5,967,414,664.02 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 894,192,633.7 | 456,755,555.78 | 1,883,148,875.67 | 1,428,292,713.49 |
| 经营活动现金流出小计 | 710,213,156.89 | 372,502,229.59 | 1,570,824,216.95 | 1,267,256,923.56 |
| 经营活动产生的现金流量净额 | 183,979,476.81 | 84,253,326.19 | 312,324,658.72 | 161,035,789.93 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 612,651,948.79 | 186,682,838.29 | 210,992,177.82 | 170,195,383.16 |
| 投资活动现金流出小计 | 592,057,730.78 | 253,364,208.05 | 433,547,468.4 | 305,521,949.06 |
| 投资活动产生的现金流量净额 | 20,594,218.01 | -66,681,369.76 | -222,555,290.58 | -135,326,565.9 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 93,876,445.51 | 52,712,334.18 | 1,160,819,163.68 | 1,012,456,015.15 |
| 筹资活动现金流出小计 | 380,532,982.33 | 223,053,965.97 | 1,170,774,930.37 | 880,496,673.81 |
| 筹资活动产生的现金流量净额 | -286,656,536.82 | -170,341,631.79 | -9,955,766.69 | 131,959,341.34 |
| 汇率变动对现金及现金等价物的影响 | -750,615.19 | -330,389.62 | 356,594.08 | 488,206.44 |
| 现金及现金等价物净增加额 | -82,833,457.19 | -153,100,064.98 | 80,170,195.53 | 158,156,771.81 |
| 期末现金及现金等价物余额 | 745,616,251.75 | 675,349,643.96 | 828,449,708.94 | 906,436,285.22 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -82,833,457.19 | - | 80,170,195.53 | - |